Treatment of uterine leiomyomata with a luteinizing hormonereleasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women-Reference-Cited by-同舟云学术

Treatment of uterine leiomyomata with a luteinizing hormonereleasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women

Published:1991-05 Issue:5 Volume:55 Page:900-905
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Nakamura Yukio,Yoshimura Yasunori,Yamada Haruhiko,Ubukata Yoshinobu,Ando Motomu,Suzuki Masahiko

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference20 articles.

1. Uterine leiomyomata: etiology, symptomatology, and management;Buttram;Fertil Steril,1981

2. Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (buserelin) as a new therapeutic approach for endometriosis;Lemay;Fertil Steril,1984

3. “Medical oophorectomy” using a long-acting GnRH agonist—a possible new approach to the treatment of endometriosis;Meldrum;J Clin Endocrinol Metab,1982

4. Luteinizing hormone-releasing hormone agonist and uterine leiomyomata: a pilot study;Maheux;Am J Obstet Gynecol,1985

5. Use of intranasal luteinizing hormone-releasing hormone agonist in uterine leiomyomas;Maheux;Fertil Steril,1987

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uterine Fibroids (Leiomyomata);Integrative Medicine;2018

2. Uterine Fibroids (Leiomyomata);Integrative Medicine;2012

3. Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium;The Journal of Steroid Biochemistry and Molecular Biology;2010-10

4. Polycystic ovary syndrome and risk of uterine leiomyomata;Fertility and Sterility;2007-05

5. Uterine Fibroids;Integrative Medicine;2007